Missed colonic adenomas in routine primary care endoscopy: a prospective tandem colonoscopy study.

Colonoscopy is the gold standard in the diagnosis of colorectal neoplasia. Several lines of independent evidence, however, suggest that a significant number of small adenomas and also some advanced lesions are missed even by experienced endoscopists. With large-scale screening colonoscopy programmes installed, information on quality of colonoscopy in primary care is essential, but not available. Between July 2006 and December 2008, a total of 40 patients (23 men and 17 women, median age: 69 years) underwent a second colonoscopy within 42 days after the first endoscopy (median: 11 days), in all cases exclusively for clinical reasons. Index colonoscopy was performed by 14 endoscopists in 6 hospitals and 4 private practices. Data on all consecutive patients were collected prospectively. A total of 98 neoplastic lesions were identified in 34 patients at the index colonoscopy, an additional 53 adenomas were removed at the second colonoscopy, 33 of them smaller than 5 mm. 25 out of 53 missed adenomas were identified between the coecum and the right colonic flexure. 12 of the additional lesions were considered significant lesions (larger than 10 mm or tubulovillous adenoma), nine of these were located between the coecum and the right colonic flexure. In 24 patients repeat colonoscopy detected adenomas not described in the original report. In eight patients a total of 12 significant lesions were removed, nine of these were located between the coecum and the right colonic flexure. About one-third of adenomas were missed in 40 routine colonoscopies, most of them only small and therefore probably of little clinical significance. However, 12 significant lesions were missed in 8 patients. Adenomas in the right colon seem to be a particular problem.

Experiences with ACE inhibitors early after acute myocardial infarction. Rationale and design of the German Multicenter Study on the Effects of Captopril on Cardiopulmonary Exercise parameters post myocardial infarction (ECCE).

Left ventricular damage by necrosis of myocardial tissue can lead to compromise of left ventricular function, to left ventricular volume increase and ultimately to development of heart failure. This sequence in the pathophysiology has been shown to be blunted by ACE inhibitors. Volume increase, however, can also be helpful in restoring stroke volume and ameliorate elevation of filling pressures. Furthermore, very early institution of ACE inhibition has failed to improve short-term mortality after myocardial infarction in one large trial. The aim of the ECCE trial therefore is, to investigate the early effects of the ACE inhibitor captopril on compromise of exercise capacity, thought to be a first measurable sign of developing heart failure. The ECCE trial is a randomized, seven-center investigation, studying the effects of ACE inhibition on oxygen uptake in a double blind, placebo controlled design in a group of 204 patients. Sample size was calculated on the basis of a pilot trial. The study design and first not unblinded data of 104 patients are presented. The population consists of predominantly male patients with mostly first myocardial infarction. They were admitted to hospital within five hours of onset of chest pain. End-diastolic volumes were normal, but ejection fraction was moderately compromised. ACE inhibition was started after the first day, but within 72 hours of onset of chest pain. After four and after twelve weeks, oxygen uptake was considerably below expected values and one third of the patients had severe compromise of exercise capacity.(ABSTRACT TRUNCATED AT 250 WORDS)